Medbox, Inc. Information to be Available through S&P Capital IQ Corporation Records Program

LOS ANGELES, May 9, 2014 /PRNewswire/ -- Medbox, Inc. (OTCQB: MDBX) (www.medbox.com), announced today that its company information would be made available via S&P Capital IQ Corporation Records Listing Program.  As part of the program, a full description of Medbox, Inc., will be published in the Daily News Section of Standard & Poors's Corporation Records, a recognized securities manual for secondary trading in up to 38 States under the Blue Sky Laws.  S&P Capital IQ Corporation Records is available in print, CD-ROM, and via the web at www.netadvantage.standardandpoors.com as well as through numerous electronic vendors.

The company information about Medbox, Inc. to be made available through this program includes an in-depth description of the Medbox, Inc's. business operations, share price, dividend history, shares outstanding, company financial position, earnings, and full income statement and balance sheet.

Dr. Bruce Bedrick, CEO of Medbox, commented, "We are proud to be part of the S&P Capital IQ program.  We look forward to our Company being much more visible to the institutional investment community."

About Medbox, Inc: 

Medbox is a leader in the development, sales and service of automated, biometrically controlled dispensing and storage systems for medicine and merchandise. Headquartered in Los Angeles, Medbox, through its wholly owned subsidiary, Medicine Dispensing Systems, offers their patented systems, software and consulting services to pharmacies, alternative medicine dispensaries and local governments in the U.S. In addition, through its wholly owned subsidiary, Vaporfection International, Inc. (www.vaporfection.com), the company offers an industry award winning medical vaporizer product. Medbox, through its newly established subsidiaries, also engages in the following ancillary services catered to the alternative medicine industry: merchant services and armored transport for cash deposits, cannabidiol R&D, real estate acquisitions and subsequent lease programs to alternative medicine dispensaries, and also alternative medicine dispensary management services.

Medbox, Inc. is a publicly traded company, and is quoted on the OTCQB, ticker symbol MDBX.  For more information on Medbox, please contact the company at (800) 762-1452 or go online to www.medbox.com. For additional due diligence information, visit: www.thedispensingsolution.com/investors

About S&P Capital IQ

S&P Capital IQ, a part of McGraw Hill Financial, is a leading provider of multi-asset class and real time data, research and analytics to institutional investors, investment and commercial banks, investment advisors and wealth managers, corporations and universities around the world. Evaluated pricing is prepared by Standard & Poor's Securities Evaluations, Inc., a part of S&P Capital IQ and a registered investment adviser with the U.S. Securities and Exchange Commission.  In the United States, research reports are prepared by Standard & Poor's Investment Advisory Services LLC, a part of S&P Capital IQ and a registered investment adviser with the U.S. Securities and Exchange Commission. S&P Capital IQ provides a broad suite of capabilities designed to help track performance, generate alpha, and identify new trading and investment ideas, and perform risk analysis and mitigation strategies. Through leading desktop solutions such as the S&P Capital IQ, Global Credit Portal and MarketScope Advisor desktops; enterprise solutions such as S&P Capital IQ Valuations; and research offerings, including Leveraged Commentary & Data, Global Markets Intelligence, and company and funds research, S&P Capital IQ sharpens financial intelligence into the wisdom today's investors need. For more information visit: www.spcapitaliq.com

Company information distributed through the Corporation Records Program is based upon information that S&P Capital IQ considers to be reliable, but neither S&P Capital IQ nor its affiliates warrant its completeness or accuracy, and it should not be relied upon as such.  This material is not intended as an offer or solicitation for the purchase or sale of any security or other financial instrument.

Contacts: 

Medbox, Inc.
Investor Relations
Stephen Hart 
Hayden IR 
+1- 917-658-7878 
[email protected] 

S&P Capital IQ Customer Contact:
Soundia O'Connor
212 438-4482
[email protected]

S&P Capital IQ Media Relations Contact:
Michael Privitera
212 438-6679
[email protected]

SOURCE Medbox, Inc.